Intrapulmonary pharmacokinetics of antibacterial agents: implications for therapeutics (Q35627857)

9 August 2017

1 reference

title

Intrapulmonary pharmacokinetics of antibacterial agents: implications for therapeutics (English)

1 reference

9 August 2017

1 reference

Loretta M Chiu

1

1 reference

9 August 2017

Guy W Amsden

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

volume

1

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

201-209

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Penetration of antibiotics into respiratory tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Some observations on the penetration of antibiotics through mucus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

In vivo penetration of antibiotics into sputum in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Influence of lipophilic character on the antibacterial activity of cephalosporins and penicillins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

General principles of antibiotic tissue penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

The use of antibiotic serum levels to predict concentrations in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

The site concentrations of antimicrobial agents in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pulmonary metabolism of foreign compounds: its role in metabolic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pulmonary disposition of antimicrobial agents: methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Penetration of piperacillin into bronchial mucosa and sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Intracellular and extracellular penetration of azithromycin into inflammatory and noninflammatory blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pharmacokinetics of quinolones with special reference to the respiratory tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pneumococcal macrolide resistance--myth or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256610

21 January 2018

Identifiers

DOI

10.1007/BF03256610

1 reference

9 August 2017

1 reference